Supplementary Material for Nemolizumab for treatment-refractory cutaneous adverse events in patients with cancer: A retrospective multi-institutional case series

Name: Supplementary Material for Nemolizumab for treatment-refractory cutaneous adverse events in patients with cancer: A retrospective multi-institutional case series
Creator: Ralina Karagenova
Published: 2026-06-18T10:12:19.817Z
Keywords: Dermatology

Karagenova, Ralina; Lee, Eudora; Fuksman , Lirit; Mu, Andrew; Lu, Charles; Lin, Chuck; Semenov, Yevgeniy

doi:10.17632/cz5rk6wdr3.1

Supplementary Material for Nemolizumab for treatment-refractory cutaneous adverse events in patients with cancer: A retrospective multi-institutional case series

Published: 18 June 2026| Version 1 | DOI: 10.17632/cz5rk6wdr3.1

Contributors:

Ralina Karagenova,

,

Description

Supplementary table and figure for the manuscript titled, "Nemolizumab for treatment-refractory cutaneous adverse events in patients with cancer: A retrospective multi-institutional case series" in the Journal of the American Academy of Dermatology.

Files

Institutions

Massachusetts General Hospital
Massachusetts, Boston

Supplementary Material for Nemolizumab for treatment-refractory cutaneous adverse events in patients with cancer: A retrospective multi-institutional case series

Description

Files

Institutions

Categories

Licence